Asclepion MCL31 Dermablate
Er:YAG Resurfacing · Er:YAG 2940nm fractional/full-field
Technology: Erbium Laser
Classification & configurations
Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)
At a glance
- New price
- $70k–$100kSource not documented
- Used asking price
- $25k–$45kSource not documented
- FDA status
- Supplies & recurring costs
- Supply details not yet documented.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- FDA
- FDA ClearedK150140
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 1 FDA record
K150140 (Asclepion Laser Technologies GmbH, 2015)
The MCL 31 Dermablate laser system is intended for coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Summary of Technical Characteristics Proposed Modified Device Un-Modified Predicate Device Un-Modified Predicate Manufacturer 510(k) MCL 31 Dermablate Asclepion Laser Technologies Dermablate Effect with Handpiece of larger spot size Asclepion Laser Technologies Dynamis Er:YAG Laser Fotona Intended Use (handpiece with larger spot size) Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Coagulation, vaporization, ablation or cutting of soft tissue (skin) in dermatology, plastic surgery, oral surgery and ophthalmology (skin around the eyes). Surgical incision/excision, vaporization and coagulation of soft tissue during any general surgery application where skin incision, tissue dissection, excision of lesions, complete or partial resection of internal organs, lesions, tissue ablation and vessel coagulation is necessary. Dermatology and Plastic Surgery, ENT Surgery, Oral/Maxillofacial Indications, Ophthalmology, Gynecology, General Surgery, Podiatry. Laser medium wavelength Er:YAG 2940 nm Er:YAG 2940 nm Er :YAG 2940 nm Principle of interaction with skin Ablation, Coagulation Ablation, Coagulation Ablation, Coagulation Energy, max. 2,5 J 1,5 J 3,0 J Power, max. 20 W 12 W 20 W Frequency, max.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: August 6, 2026 · How we verify
Axis runs $0–$100k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Asclepion |
|---|---|
| Company | Not published |
| Parent company | Asclepion |
| Brand owner | Asclepion |
| Built by (OEM) | Asclepion Laser Technologies GmbH |
| Category | Er:YAG Resurfacing |
| Technology | Er:YAG 2940nm fractional/full-field |
| FDA status | FDA Cleared |
| 510(k) citation | K150140 |
| New price range | $70k–$100k |
| Used asking range | $25k–$45k |
| Consumables | Not published |
| Launch year | 2013 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
German erbium with thermal mode
FDA & regulatory detailClearance timeline, authorization route and citation notes
FDA-cleared indications (verbatim)
K150140 (Asclepion Laser Technologies GmbH, 2015)
The MCL 31 Dermablate laser system is intended for coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Summary of Technical Characteristics Proposed Modified Device Un-Modified Predicate Device Un-Modified Predicate Manufacturer 510(k) MCL 31 Dermablate Asclepion Laser Technologies Dermablate Effect with Handpiece of larger spot size Asclepion Laser Technologies Dynamis Er:YAG Laser Fotona Intended Use (handpiece with larger spot size) Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Coagulation, vaporization, ablation or cutting of soft tissue (skin) in dermatology, plastic surgery, oral surgery and ophthalmology (skin around the eyes). Surgical incision/excision, vaporization and coagulation of soft tissue during any general surgery application where skin incision, tissue dissection, excision of lesions, complete or partial resection of internal organs, lesions, tissue ablation and vessel coagulation is necessary. Dermatology and Plastic Surgery, ENT Surgery, Oral/Maxillofacial Indications, Ophthalmology, Gynecology, General Surgery, Podiatry. Laser medium wavelength Er:YAG 2940 nm Er:YAG 2940 nm Er :YAG 2940 nm Principle of interaction with skin Ablation, Coagulation Ablation, Coagulation Ablation, Coagulation Energy, max. 2,5 J 1,5 J 3,0 J Power, max. 20 W 12 W 20 W Frequency, max.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Erbium — Er:YAG 2940nm fractional/full-field
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
510(k) numbers
Parent company: Asclepion
Legal manufacturer: Asclepion Laser Technologies GmbH (Germany)
Applicant on the FDA record
Asclepion Laser Technologies GmbHThe applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Consumable costs are not documented yet.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Asclepion MCL31 Dermablate data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History1 tracked change
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Asclepion MCL31 Dermablate — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.